Rep. Josh Gottheimer Sells Off Shares of U.S. Physical Therapy, Inc. (NYSE:USPH)

Representative Josh Gottheimer (D-New Jersey) recently sold shares of U.S. Physical Therapy, Inc. NYSE: USPH. In a filing disclosed on May 14th, the Representative disclosed that they had sold between $1,001 and $15,000 in U.S. Physical Therapy stock on April 17th. The trade occurred in the Representative's "MORGAN STANLEY - SELECT UMA ACCOUNT # 1" account.

Representative Josh Gottheimer also recently made the following trade(s):

• Purchased $1,001 - $15,000 in shares of RTX NYSE: RTX on 4/23/2025.
• Purchased $1,001 - $15,000 in shares of Cheniere Energy NYSE: LNG on 4/22/2025.
• Purchased $1,001 - $15,000 in shares of Techtronic Industries OTCMKTS: TTNDY on 4/21/2025.
• Purchased $1,001 - $15,000 in shares of Tri Pointe Homes NYSE: TPH on 4/21/2025.
• Purchased $1,001 - $15,000 in shares of Perusahaan Perseroan (Persero) PT Telekomunikasi Indonesia Tbk NYSE: TLK on 4/21/2025.
• Sold $1,001 - $15,000 in shares of KKR & Co. Inc. NYSE: KKR on 4/21/2025.
• Purchased $1,001 - $15,000 in shares of D.R. Horton NYSE: DHI on 4/21/2025.
• Purchased $1,001 - $15,000 in shares of Home Depot NYSE: HD on 4/21/2025.
• Sold $1,001 - $15,000 in shares of Hillman Solutions NASDAQ: HLMN on 4/17/2025.
• Sold $1,001 - $15,000 in shares of AbbVie NYSE: ABBV on 4/17/2025.

U.S. Physical Therapy Trading Down 2.6%

Shares of USPH stock traded down $2.04 on Wednesday, hitting $77.36. 84,227 shares of the stock traded hands, compared to its average volume of 111,049. The firm's 50-day moving average price is $71.96 and its two-hundred day moving average price is $83.49. The company has a debt-to-equity ratio of 0.27, a quick ratio of 1.78 and a current ratio of 1.78. The stock has a market capitalization of $1.18 billion, a PE ratio of 82.30, a PEG ratio of 3.54 and a beta of 1.44. U.S. Physical Therapy, Inc. has a twelve month low of $62.77 and a twelve month high of $105.80.

U.S. Physical Therapy (NYSE:USPH - Get Free Report) last announced its quarterly earnings results on Wednesday, May 7th. The company reported $0.48 earnings per share for the quarter, beating the consensus estimate of $0.46 by $0.02. The firm had revenue of $183.79 million for the quarter, compared to analysts' expectations of $176.78 million. U.S. Physical Therapy had a net margin of 3.54% and a return on equity of 8.11%. The company's revenue was up 18.0% compared to the same quarter last year. During the same quarter in the previous year, the company posted $0.51 EPS. As a group, analysts anticipate that U.S. Physical Therapy, Inc. will post 2.67 EPS for the current year.

U.S. Physical Therapy Dividend Announcement

The company also recently declared a quarterly dividend, which will be paid on Friday, June 13th. Stockholders of record on Friday, May 23rd will be given a dividend of $0.45 per share. The ex-dividend date is Friday, May 23rd. This represents a $1.80 annualized dividend and a dividend yield of 2.33%. U.S. Physical Therapy's payout ratio is 82.57%.

Insiders Place Their Bets

In other U.S. Physical Therapy news, COO Graham D. Reeve sold 1,730 shares of the business's stock in a transaction dated Friday, March 7th. The shares were sold at an average price of $82.11, for a total transaction of $142,050.30. Following the sale, the chief operating officer now directly owns 7,168 shares in the company, valued at $588,564.48. This represents a 19.44% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website. Insiders own 2.00% of the company's stock.

Analyst Ratings Changes

Several research analysts have recently weighed in on USPH shares. JMP Securities reissued a "market outperform" rating and set a $113.00 price target on shares of U.S. Physical Therapy in a research report on Tuesday, April 22nd. Barrington Research lowered their price target on shares of U.S. Physical Therapy from $108.00 to $98.00 and set an "outperform" rating on the stock in a research report on Friday, February 28th. JPMorgan Chase & Co. decreased their target price on shares of U.S. Physical Therapy from $120.00 to $110.00 and set an "overweight" rating on the stock in a research report on Wednesday, March 19th. StockNews.com raised shares of U.S. Physical Therapy from a "sell" rating to a "hold" rating in a research report on Thursday, May 8th. Finally, William Blair reaffirmed a "market perform" rating on shares of U.S. Physical Therapy in a research report on Thursday, February 27th. Two investment analysts have rated the stock with a hold rating, four have given a buy rating and one has assigned a strong buy rating to the company's stock. Based on data from MarketBeat, the stock currently has an average rating of "Moderate Buy" and a consensus price target of $109.00.

Institutional Inflows and Outflows

Large investors have recently bought and sold shares of the stock. CBIZ Investment Advisory Services LLC lifted its position in U.S. Physical Therapy by 59.8% in the fourth quarter. CBIZ Investment Advisory Services LLC now owns 326 shares of the company's stock valued at $29,000 after buying an additional 122 shares during the last quarter. Mitsubishi UFJ Asset Management Co. Ltd. increased its stake in U.S. Physical Therapy by 952.4% during the first quarter. Mitsubishi UFJ Asset Management Co. Ltd. now owns 442 shares of the company's stock worth $32,000 after purchasing an additional 400 shares during the period. Point72 Asia Singapore Pte. Ltd. purchased a new stake in U.S. Physical Therapy during the fourth quarter worth about $39,000. Venturi Wealth Management LLC increased its stake in U.S. Physical Therapy by 3,200.0% during the fourth quarter. Venturi Wealth Management LLC now owns 726 shares of the company's stock worth $64,000 after purchasing an additional 704 shares during the period. Finally, Fifth Third Bancorp increased its stake in U.S. Physical Therapy by 34.6% during the first quarter. Fifth Third Bancorp now owns 1,030 shares of the company's stock worth $75,000 after purchasing an additional 265 shares during the period.

About Representative Gottheimer

Josh Gottheimer (Democratic Party) is a member of the U.S. House, representing New Jersey's 5th Congressional District. He assumed office on January 3, 2017. His current term ends on January 3, 2027. Gottheimer (Democratic Party) is running for re-election to the U.S. House to represent New Jersey's 5th Congressional District. He declared candidacy for the 2026 election. Gottheimer is also running for election for Governor of New Jersey. He declared candidacy for the Democratic primary scheduled on June 10, 2025. Gottheimer attended the University of Pennsylvania for his undergraduate degree. He became a Thouron Fellow at Oxford and attended Harvard Law School. Gottheimer worked as a speech writer under former President Bill Clinton (D), assisting with two State of the Union addresses, among other projects. Before running for Congress, he worked for Microsoft as a general manager for corporate strategy.

U.S. Physical Therapy Company Profile

U.S. Physical Therapy, Inc operates outpatient physical therapy clinics. The company operates through Physical Therapy Operations and Industrial Injury Prevention Services segments. The company provides pre-and post-operative care and treatment for orthopedic-related disorders, sports-related injuries, preventative care, rehabilitation of injured workers, and neurological-related injuries.